Home
About
Publications Trends
Recent Publications
Expert Search
Archive
systemic chemotherapy
What are the Side Effects of Systemic Chemotherapy?
Because chemotherapy drugs target rapidly dividing cells, they can also affect healthy cells such as those in the bone marrow, digestive tract, and hair follicles. Common side effects include:
Fatigue
Nausea and vomiting
Hair loss
Increased risk of infection
Anemia
Diarrhea or constipation
While these side effects can be challenging, many of them can be managed with supportive care and medications.
Frequently asked queries:
What is Systemic Chemotherapy?
How Does Systemic Chemotherapy Work?
When is Systemic Chemotherapy Used?
What Types of Drugs are Used in Systemic Chemotherapy?
What are the Side Effects of Systemic Chemotherapy?
How is the Effectiveness of Systemic Chemotherapy Monitored?
What are the Advances in Systemic Chemotherapy?
What Should Patients Know Before Starting Systemic Chemotherapy?
What Are the Benefits of Remote Monitoring?
What Role Does the Rb Protein Play?
What Can Be Done to Manage Muscle Weakness in Cancer Patients?
How Can Patients Find an Advocate?
Can You Provide an Example of a Notable Study Published in JBHI?
How is Performance Status Assessed?
What Topics are Covered?
What are the therapeutic implications of MHC in cancer?
Are All Nuts Equally Beneficial?
How do antibiotic-resistant infections impact cancer treatment?
What is the Role of BER in Cancer Prevention?
What Types of Cancer Could Benefit from Cyclosporine A?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe